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Objective: To discuss the effect and mechanism of miR-34a on the proliferation,
apoptosis and invasion of laryngeal carcinoma cells.
Methods: The laryngeal squamous carcinoma Hep2 cells were transiently transfected
with miR-34a mimics and miR-34a NC. The MTT, colony-forming assay, Hoechst
staining and AnnexinV-PI double staining ﬂow cytometry were employed to detect the
effect of miR-34a on the viability and apoptosis of laryngeal squamous carcinoma Hep2
cells; Transwell assay to defect the effect of miR-34a on the migration and invasion of
laryngeal squamous carcinoma Hep2 cells; western blot and RT-PCR assay to defect the
effect of miR-34a mimics on the expression of survivin and Ki-67 mRNA in laryngeal
squamous carcinoma Hep2 cells.
Results: Compared withmiR-34a NC group, the cell viability in miR-34mimics group was
signiﬁcantly decreased (P < 0.01), the cell apoptosis rate was signiﬁcantly increased
(P < 0.01), the abilities of cell migration and invasion were signiﬁcantly reduced (P < 0.01)
and the expression of survivin and Ki-67 mRNA was signiﬁcantly decreased (P < 0.01).
Conclusions: The increased expression of miR-34a can induce the apoptosis of Hep2
laryngeal carcinoma cells and inhibit the cell proliferation and invasion, which is related
to the down-regulated expression of survivin and Ki-67.1. Introduction
The laryngeal squamous cell carcinoma is the common ma-
lignant tumor in the head and neck in China, where the laryngeal
squamous cell carcinoma is the major pathological pattern that
accounts for over 90%. The main treatment for laryngeal squa-
mous cell carcinoma is the surgery and it is also accompanied by
the chemotherapy and radiation therapy. But the function of
swallowing and ventilator phonation for patients in the advanced
stage will be greatly affected and those patients will ﬁnd that ‘it is
hard to tell about their sufferings’. The prognosis and ﬁve-year
survival rate for patients in the middle and advanced stage
were not good, because the invasion and migration of malignant
tumor would cause the death of patients in the end [1,2]. Thepathogenesis of laryngeal carcinoma has not been clear. The
possible cause might include the smoking, drinking, virus
infection, air pollution, activation of oncogenes and inactivation
of tumor suppressor genes [2]. Therefore, to seek the effective
and speciﬁc tumor marker will be of critical signiﬁcance for
the treatment of laryngeal squamous cell carcinoma.
ThemiRNA is some kind of highly conserved endogenous non-
coding small molecule RNA, with the function of oncogenes or
tumor suppressor genes, which can be bound with the region of 30-
UTR of target gene mRNA to inhibit the translation of target gene
and thus inhibit the expression of target gene. Besides, it is closely
related to the development and progression of tumor and plays a
key role in the proliferation, apoptosis, invasion and migration of
tumor. It is been proved that many kinds of miRNA had the dif-
ferential expression in laryngeal squamous cell carcinoma,
including the miR-34 family [3,4]. The miR-34 family is widely
found in the nematodes, arthropods and mammals, including miR-
34a, miR-34b and miR-34c. Researches were mainly focused on
miR-34a/c. It has been proved that miR-34c had the obvious in-
hibition effect on the cell cycle and proliferation of laryngeal car-
cinoma cellsHep2 [5]. But there have been limited researches on the
effect ofmiR-34a in laryngeal squamous cell carcinoma.However,ticle under the CC BY-NC-ND license (http://
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34a in laryngeal squamous cell carcinoma was signiﬁcantly lower
than that in the paracarcinoma tissues. Besides, miR-34a could
affect the proliferation and invasion of cancer cells through the
proteins such as targeted survivin. Therefore, in this study, based on
previous researches, the liposomes were transfected with miR-34a
mimics and miR-34a NC to defect the changes in the proliferation,
apoptosis and invasion of laryngeal squamous carcinoma Hep2
cells after the transfection and discuss the related mechanism.
2. Materials and methods
2.1. Materials
The human laryngeal squamous carcinoma Hep2 cells were
purchased from Cell Bank, Chinese Academy of Sciences (Item
No. TCHu21).
The rabbit anti-survivin and Ki-67 monoclonal antibody was
purchased from Epitomics; the methyl thiazolyl tetrazolium from
Gibco; the fetal bovine serum from Hyclone; Hoechst 33258
staining kit and AnnexinV-PI double staining ﬂow cytometry kit
from Beyotime Biotechnology (Item No. C1018 and C1063);
miR-34a mimics and miR-34a NC from Guangzhou RiboBio;
Transwell chamber from Corning (Item No. 3413).
The dual mini vertical electrophoresis apparatus and mini
transfer electrophoresis apparatus were purchased from Beijing
Liuyi Biotechnology Co., Ltd.; ChemiDocTM XRS gel imaging
system from Bio-Rad; TS100 inverted microscope from Nikon;
FACS Calibur ﬂow cytometry from BD.
2.2. Methods
2.2.1. MTT to detect cell viability
Cells were seeded onto 96-well plate. When the conﬂuency
of cells reached to 50%, Lipofectamine™2000 was transfected
with miR-34a mimics and miR-34a NC respectively. A total of
48 h after the transfection, 20 mL 5 mg/mL MTT was added for
the continuous culture of 4 h and then the culture medium was
sucked out. Afterwards, 150 mL DMSO was added in each well
and then it was shaken to fully dissolve the crystals. CD value
was measured at 560 nm of analyzer of enzyme-linked immu-
nosorbent assay. The cell relative viability (%) = (OD value of
experimental group/OD value of control group) × 100%.
2.2.2. Colony formation assay
The human laryngeal squamous carcinoma Hep2 cells were
seeded on 96-well plate. When the conﬂuency of cells reached to
50%, Lipofectamine™2000 was transfected with miR-34a
mimics and miR-34a NC respectively. A total of 48 h after the
transfection, the staining solution with 10% formaldehyde and
0.1% crystal violet was used for the ﬁxed staining. It was placed
at room temperature for 30 min. Afterwards, the staining solu-
tion was gently ﬂung off and each well was washed with the
distilled water. The culture plate was inverted on the absorbent
paper to suck out the water. Then the photo was taken and the
analysis was performed.
2.2.3. AnnexinV-PI double staining ﬂow cytometry
Cells were seeded onto 6-well plate. When the conﬂuency of
cells reached to 50%, Lipofectamine™2000 was transfected with
miR-34a mimics and miR-34a NC respectively. The operationprocedure should be in accordancewith themanual of kit and itwas
tested on the machine. According to the manual of Annexin V-
FITC/PI cell apoptosis test kit, it was digested with 0.25% trypsin
and washed with PBS. After being centrifuged at 2000 r/min for
5 min, cells were collected. Then 500 mL Binding Buffer, 5 mL
Annexin V-FITC and 5 mL PI 5 were added in turn. Afterwards,
they were mixed and reacted at room temperature and in a dark
place for 10min.Theﬂowcytometry testwas performedwithin1 h.
2.2.4. Hoechst staining
The human laryngeal squamous carcinoma Hep2 cells were
seeded on 6-well plate. When the conﬂuency of cells reached to
50%, Lipofectamine™2000was transfected with miR-34amimics
andmiR-34aNC, respectively.A total of 48h after the transfection,
cells were digested and collected. Then the operation procedure
was done in accordancewith themanual ofHoechst 33258 staining
kit. It was ﬁxed with 4% paraformaldehyde for 15 min and then
washedwith PBS for 3 times. The Hoechst 33258 staining solution
was added for the staining in a dark place for 15 min. After being
washed with PBS for 3 times, it was observed under the ﬂuores-
cence microscope and the photos were taken.
2.2.5. Migration assay
The human laryngeal squamous carcinoma Hep2 cells were
seeded on 6-well plate. When the conﬂuency of cells reached to
50%, Lipofectamine™2000 was transfected with miR-34a
mimics and miR-34a NC respectively. A total of 48 h after the
transfection, the cells were digested and then added in Transwell
upper chamber. The DMEM with 5% fetal bovine serum was
added in the lower chamber to be cultured for 24 h. Afterwards,
the Transwell chamber was taken out and washed. It was then
ﬁxed with paraformaldehyde and stained with crystal violet. The
stained cytoplasm appeared to be violet. The number of
membrane-penetrating cells in ﬁve ﬁelds was counted under the
inverted optical microscope and the mean number of cells for
each ﬁeld was calculated to represent the migration ability of
cells. Each experiment had three repeats.
2.2.6. Invasion assay
Matrigel gel was evenly paved on the micromembrane
(8 mm) of Transwell chamber to be prepared as the gel for further
use. Other operations were the same as ones in section 2.2.5. The
number of membrane-penetrating cells in ﬁve ﬁelds was counted
under the inverted optical microscope and the mean number of
cells for each ﬁeld was calculated to represent the migration
ability of cells. Each experiment had three repeats.
2.2.7. RT-PCR
The total RNA was extracted according to the manual of
trizol kit (Invitrogen) in the situation without RNAase. The
micro UV spectrophotometer was employed to detect the ab-
sorption value of samples at 260 nm and 280 nm to analyze the
purity of RNA. The OD260/OD280 ratio within 1.8–2.0 indi-
cated the qualiﬁed purity of RNA. The primers were as follows.
Survivin forward primer: 50-GTTGCGCTTTCCTTTCTGTC-30,
reverse primer: 50-TCTCCGCAGTTTCCTCAAAT-30; Ki-67
forward primer: 50-ACTCCAGTTGCCAGTGAT-30, reverse
primer: 50-GACTTCGGCTGATAGACA-30; GADPH forward
primer: 50-AGCCACATCGCTCAGACA-30, reverse primer: 50-
TGGACTCCACGACGTACT-30. The one-step RT-PCR kit was
employed to reversely transcribe RNA into cDNA and then
Table 1
Effect of miR-34a on expression of survivin and Ki-67 mRNA and
protein in laryngeal squamous carcinoma Hep2 cells.
Group mRNA expression Protein expression
Survivin/
GAPDH
Ki-67/
GAPDH
Survivin/
GAPDH
Ki-67/
GAPDH
MiR-34a
NC group
0.32 ± 0.04 0.09 ± 0.01 0.78 ± 0.08 0.28 ± 0.03
MiR-34a
mimics
group
0.49 ± 0.04** 0.10 ± 0.02** 1.06 ± 0.11** 0.37 ± 0.04**
Compared with miR-34a NC group, **P < 0.01.
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product was used for the further testing with 2% agarose gel.
The primers were added in 25 mL PCR system. The reaction
conditions included the denaturation at 94 C for 45 s, rena-
turation at 59 C for 45 s and extension at 72 C for 60 s, with 35
cycles in total.
2.2.8. Western blot
TheRIPA lysis buffer with the certain quantitywas added in the
collected cells. It was put in Vortex instrument for 30 s of shaking
every 10min. After 40min, it was centrifuged at 4 C and 10000 r/
min for 10min. The supernatant was sucked carefully to obtain the
total protein. The protein concentration was measured with BCA
kit. The protein loading buffer was treated with SDS gel electro-
phoresis and then it was transferred with the wet method. Then the
ﬁlm was immersed into the primary antibody solution (Survivin
and Ki-67, with the dilution ratio of 1:100) for the incubation at
4 C over night. After being washed, it was immersed into the
secondary antibody solution (1:100) for the incubation at the room
temperature for 1–2 h. Afterwards, the ﬁlm was taken out and
washed, while ECL reagent was added on the ﬁlm for the exposure
in the gel imaging system. Statistics was performed on the gray
value of each antibody band using ‘Quantity one’ software.
2.3. Statistical analysis
The results were expressed as mean ± SD, with three repeats
for each set of data at least. The t test was employed and
P < 0.05 was meant to be signiﬁcant difference. All data were
treated using SPSS 17.0.
3. Results
3.1. Effect of miR-34a on viability and number of clones
of laryngeal squamous carcinoma Hep2 cells
It was shown that the viability of laryngeal squamous carci-
nomaHep2 cells in miR-34amimics group [(52.39 ± 5.96)%] was
signiﬁcantly reduced compared with miR-34a NC group
[(94.48 ± 8.67)%] (P < 0.01). The results showed that compared
with miR-34a NC group (125.49 ± 9.68), the number of clones in
miR-34a mimics group was signiﬁcantly reduced (48.37 ± 4.95)
(P < 0.01).
3.2. Effect of miR-34a on proliferation and apoptosis of
laryngeal squamous carcinoma Hep2 cells
According to the results of Hoecsht staining, the apoptosis
rate of laryngeal squamous carcinoma Hep2 cells in miR-34a
mimics group [(43.38 ± 5.67)%] was signiﬁcantly increased
compared with miR-34a NC group [(5.06 ± 0.63)%] (P < 0.01).
According to the results of ﬂow cytometry, compared with miR-
34a NC group [(9.10 ± 0.71)%], the apoptosis rate of laryngeal
squamous carcinoma Hep2 cells in miR-34a mimics group
[(44.47 ± 3.58)%] was signiﬁcantly increased (P < 0.01).
3.3. Effect of miR-34a on migration and invasion
abilities of laryngeal squamous carcinoma Hep2 cells
The number of migrated cells in miR-34a mimics group
(62.28 ± 5.98) was signiﬁcantly lower than that in miR-34a NCgroup (159.32 ± 8.96) (P < 0.01). The number of invaded cells
in miR-34a mimics group (69.26 ± 6.94) was signiﬁcantly lower
than that in miR-34a NC group (188.45 ± 10.95) (P < 0.01).
3.4. Effect of miR-34a on expression of survivin and Ki-
67 mRNA in laryngeal squamous carcinoma Hep2 cells
As shown in Table 1, compared with miR-34a NC group, the
expression of survivin and Ki-67 mRNA in miR-34a mimics
group was signiﬁcantly reduced (P < 0.05); as shown in Table 1,
compared with miR-34a NC group, the expression of survivin
and Ki-67 protein in miR-34a mimics group was signiﬁcantly
reduced (P < 0.05).
4. Discussion
ThemiRNA is some kind of highly conserved endogenous non-
coding small molecule RNA, which can be bound with the region
of 30-UTRof target genemRNA to regulate the translation of target
gene and be involved in the development and progression of tumor.
It is been proved that miRNAs could regulate over 60% human
protein-coding genes and had the signiﬁcant impact on the
expression of genes. Besides, the abnormal expression miRNA in
tumors can be divided into two types. One is called as ‘tumor
suppressor miRNA’. Its expression is reduced or the function is
lost, playing the role like tumor suppressor genes. The other one is
‘oncogene miRNA’. Its expression is increased, playing the role
like oncogenes [8,9]. Therefore, the abnormal expression ofmiRNA
can be treated as themarker of tumor risk, diagnosis and prognosis,
even the targeted therapybased onmiRNA.miR-34a is themember
of miR-34 family, which is located in 1p36.23, with the low
expression in many tumors such as the cervical carcinoma, gastric
carcinoma and hepatic carcinoma. It was also involved in the
development and progression of tumors and the lymph node
metastasis [10–12]. Shen et al. [6] performed RT-PCR assay and
proved the low expression of miR-34a in laryngeal squamous cell
carcinoma. The expression of miR-34a was negatively related to
the pathological distribution, lymph node metastasis and clinical
staging of patients with laryngeal squamous cell carcinoma, while
positively related to the survival rate. miR-34a mimics could
signiﬁcantly inhibit the cell proliferation and down-regulate the
expression of survivin protein and also block the cell cycle at the
stage of G0/G1. Li et al. [7] proved that the expression of miR-34a
was decreased in the laryngeal squamous cell carcinoma and the
exogenous supply of miR-34a could signiﬁcantly inhibit the pro-
liferation and migration of cells. It indicated that miR-34a played
the role of tumor suppressor gene in the laryngeal squamous cell
carcinoma and it was also closely related to the development and
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metastasis. Therefore, in this study, the laryngeal squamous car-
cinoma Hep2 cells was transiently transfected with miR-34a
mimics and miR-34a NC and The MTT, colony-forming assay,
Hoechst staining, AnnexinV-PI double staining ﬂow cytometry
and Transwell assaywere employed to detect the effect ofmiR-34a
on the proliferation, apoptosis, migration and invasion of laryngeal
squamous carcinoma Hep2 cells. The results showed that the cell
viability, number of cell cloning, number of cell migration and
invasion in miR-34a mimics group were signiﬁcantly lower than
that in miR-34a NC group, while the cell apoptosis rate was
signiﬁcantly higher than that inmiR-34aNCgroup. It indicated that
the increased expression of laryngeal squamous carcinoma Hep2
cells could signiﬁcantly induce the cell apoptosis and inhibit the
cell proliferation,migration and invasion.Meanwhile,Nie et al. [13]
andZhao et al. [14] proved that the increased expression ofmiR-34a
in esophageal squamous cell carcinoma and osteosarcoma cells
could signiﬁcantly induce the apoptosis of cancer cells and inhibit
the colony-formation, migration and invasion of cells, which were
in line with the ﬁndings of this study.
The development and progression of tumor is a process that
involves multiple factors and steps, being presented as the acti-
vation of oncogenes and inactivation of tumor suppressor genes
ﬁnally. By regulating the expression of oncogenes and tumor
suppressor genes, miRNAs play a key role in the development
and progression of tumors. The survivin is also named as the
apoptosis inhibitor-5, as the new member of apoptosis inhibitor
protein family. It is situated in 17q25 and the strongest apoptosis
inhibitor found so far, with the functions of inhibiting the cell
apoptosis and maintaining the mitosis. The survivin can affect the
apoptosis pathway of caspase 3 through the indirect or direct way
to inhibit the cell apoptosis and promote the cell proliferation.
Survivin had the high expression in most of human tumor tissues,
but nearly had no expression in the normal mature tissues [15].
According to the immunohistochemistry performed by Wang
et al. [16], the expression of survivin and Ki-67 was gradually
increased in the vocal cord polyp tissues, laryngeal precancerous
lesions and laryngeal carcinoma tissues. The expression of them
was positively correlated. Ki-67 is some kind of nuclear antigen
related to the cell proliferation, which was ﬁrstly found by Gerdes
et al. in 1983. It is closely related to the cell mitosis. Except no
expression at G0 phase of cell cycle, it is expressed in other
phases. Its expression is highest at M phase and can be regarded
as the marker of cell proliferation. It can reliably reﬂect the
proliferation rate of tumors and it is related to the development,
progression, metastasis and prognosis of many tumors. Acikalin
et al. [17] reported the results of immunohistochemistry and also
proved the over-expression of Ki-67 in the laryngeal carcinoma
tissues, which was closely related to the tumor staging and lymph
node metastasis. It indicated that the down-regulated expression
of survivin and Ki-67 could signiﬁcantly induce the cell
apoptosis and inhibit the proliferation and invasion of cells.
Therefore in this study, thewestern blot andRT-PCRassaywere
employed to detect the expressionof survivin andKi-67 protein and
mRNA in cells after the transfection of miR-34a mimics and miR-
34a NC. The results showed that, compared with miR-34a NC
group, the expressions of survivin and Ki-67 protein and mRNA
were all signiﬁcantly decreased in miR-34a mimics group. The
previous research also proved that the over-expression of miR-34a
could reduce the viability and invasion of human papillomavirus
positive cervical carcinoma cells through the targeted regulation of
expression of E23F and survivin [10]. The increased expression ofmiR-34a in the gastric cancer cells could signiﬁcantly inhibit the
proliferation, migration and invasion of gastric cancer cells, which
was related to the decreased expression of survivin [11]. It indicated
that the increased expression of miR-34a in laryngeal carcinoma
Hep2 cells could signiﬁcantly reduce the expression of survivin and
Ki-67 protein and mRNA and thus induce the cell apoptosis and
inhibit the proliferation and invasion of cells.Meanwhile, a research
also proved thatmiR-34a could signiﬁcantly increase the sensitivity
of gastric cancer cells to the cisplatin, which was related to PI3K/
AKT/survivin pathway [18]. Besides, the effect of miR-34a on the
proliferation, apoptosis, migration and invasion of tumors was
related tomany signaling pathways [19,20]. Accordingly, the further
studies will discuss the speciﬁc signaling pathways regarding the
effect of miR-34a on the proliferation and apoptosis and invasion
of Hep2 gastric cancer cells.
In conclusion, miR-34a mimics could signiﬁcantly reduce the
viability of Hep2 cells, induce the cell apoptosis and inhibit the
migration and invasion of cells, which were realized by down-
regulating the expression of survivin and Ki-67.
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